1 enrolling by invitation, 1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Enrolling by invitation 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow HVA: new trials by email Literature Review of HVA trials Research Report on HVA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL). HVA - Newly Diagnosed Mixed Phenotype Acute Leukemia (MPAL) | Phase 2 | Enrolling by invitation | Guangdong Second Provincial General Hospital | 40 | 2026-04-01 | 2026-04-08 |
| HVA vs IA/DA or VA in the Treatment of ND HR-AML HVA, VA, Standard Chemotherapy - Newly Diagnosed Acute Myeloid Leukemia With High Risk | Phase 3 | Recruiting | Nanfang Hospital, Southern Medical University | 876 | 2025-01-01 | 2025-02-06 |
Leukemia, Biphenotypic, Acute (1) · Leukemia, Myeloid, Acute (1)
Guangdong Second Provincial General Hospital (1) · Nanfang Hospital, Southern Medical University (1)
China (2)
Guopan Yu (1)